210 related articles for article (PubMed ID: 10547574)
41. Expression and amplification of cyclin D1 in primary breast carcinomas: relationship with histopathological types and clinico-pathological parameters.
Naidu R; Wahab NA; Yadav MM; Kutty MK
Oncol Rep; 2002; 9(2):409-16. PubMed ID: 11836618
[TBL] [Abstract][Full Text] [Related]
42. p27 downregulation and metallothionein overexpression in gastric cancer patients are associated with a poor survival rate.
Galizia G; Ferraraccio F; Lieto E; Orditura M; Castellano P; Imperatore V; La Manna G; Pinto M; Ciardiello F; La Mura A; De Vita F
J Surg Oncol; 2006 Mar; 93(3):241-52. PubMed ID: 16482605
[TBL] [Abstract][Full Text] [Related]
43. Study on the different expression of molecular markers between cardiac cancer and distal gastric cancer and their correlations with clinicopathological features.
Ye YW; Fu H; Zhou Y; Du CY; Li BZ; Zhu L; Shi YQ
Dig Surg; 2009; 26(5):384-91. PubMed ID: 19923826
[TBL] [Abstract][Full Text] [Related]
44. Cyclin D1 protein is overexpressed in hyperplasia and intraductal carcinoma of the breast.
Alle KM; Henshall SM; Field AS; Sutherland RL
Clin Cancer Res; 1998 Apr; 4(4):847-54. PubMed ID: 9563877
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of cell cycle protein expression in gastric cancer: cyclin B1 expression and its prognostic implication.
Begnami MD; Fregnani JH; Nonogaki S; Soares FA
Hum Pathol; 2010 Aug; 41(8):1120-7. PubMed ID: 20334896
[TBL] [Abstract][Full Text] [Related]
46. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.
Tut VM; Braithwaite KL; Angus B; Neal DE; Lunec J; Mellon JK
Br J Cancer; 2001 Jan; 84(2):270-5. PubMed ID: 11161387
[TBL] [Abstract][Full Text] [Related]
47. Paradoxical expression of maspin in gastric carcinomas: correlation with carcinogenesis and progression.
Yu M; Zheng H; Tsuneyama K; Takahashi H; Nomoto K; Xu H; Takano Y
Hum Pathol; 2007 Aug; 38(8):1248-55. PubMed ID: 17490717
[TBL] [Abstract][Full Text] [Related]
48. Strong association of lymph node metastasis with intraperitoneal free cancer cell (IFCC) in advanced gastric cancer.
Yamashita K; Sakuramoto S; Kikuchi S; Katada N; Kobayashi N; Watanabe M
Hepatogastroenterology; 2008; 55(86-87):1873-7. PubMed ID: 19102412
[TBL] [Abstract][Full Text] [Related]
49. The tumor suppressor gene LKB1 is associated with prognosis in human breast carcinoma.
Shen Z; Wen XF; Lan F; Shen ZZ; Shao ZM
Clin Cancer Res; 2002 Jul; 8(7):2085-90. PubMed ID: 12114407
[TBL] [Abstract][Full Text] [Related]
50. [Malignancy of colorectal cancer analyzed by expression of cyclin D1].
Maeda K; Kang SM; Ogawa M; Chung YS; Onoda N; Nakata B; Nishiguchi Y; Ikehara T; Okuno M; Sowa M
Gan To Kagaku Ryoho; 1997 Jul; 24 Suppl 2():259-62. PubMed ID: 9263512
[TBL] [Abstract][Full Text] [Related]
51. Overexpression of cyclin D1 is associated with poor prognosis in extremity soft-tissue sarcomas.
Kim SH; Lewis JJ; Brennan MF; Woodruff JM; Dudas M; Cordon-Cardo C
Clin Cancer Res; 1998 Oct; 4(10):2377-82. PubMed ID: 9796968
[TBL] [Abstract][Full Text] [Related]
52. [Expression of cyclin D1 and vascular endothelial growth factor(VEGF) in non-small cell lung carcinoma and their association with the prognosis].
Liang RY; Liao ZS; Jiang SP; Zhang W; Li JG; Zheng DH
Ai Zheng; 2003 Jan; 22(1):86-90. PubMed ID: 12561444
[TBL] [Abstract][Full Text] [Related]
53. Cyclin D1 overexpression is not a specific grouping marker, but may collaborate with CDC37 in myeloma cells.
Katayama Y; Sakai A; Okikawa Y; Oue N; Asaoku H; Sasaki A; Imanaka F; Tsujimoto T; Takimoto Y; Masuda R; Nakaju N; Otsuki T; Yasui W; Kimura A
Int J Oncol; 2004 Sep; 25(3):579-95. PubMed ID: 15289859
[TBL] [Abstract][Full Text] [Related]
54. The expression of cyclins D1 and E in predicting short-term survival in squamous cell carcinoma of the lung.
Anton RC; Coffey DM; Gondo MM; Stephenson MA; Brown RW; Cagle PT
Mod Pathol; 2000 Nov; 13(11):1167-72. PubMed ID: 11106072
[TBL] [Abstract][Full Text] [Related]
55. Expression of cyclin D1 splice variants is differentially associated with outcome in non-small cell lung cancer patients.
Li R; An SJ; Chen ZH; Zhang GC; Zhu JQ; Nie Q; Xie Z; Guo AL; Mok TS; Wu YL
Hum Pathol; 2008 Dec; 39(12):1792-801. PubMed ID: 18715616
[TBL] [Abstract][Full Text] [Related]
56. Overexpression and localization of cyclin D1 mRNA and antigen in esophageal cancer.
Naitoh H; Shibata J; Kawaguchi A; Kodama M; Hattori T
Am J Pathol; 1995 May; 146(5):1161-9. PubMed ID: 7747810
[TBL] [Abstract][Full Text] [Related]
57. Prognostic benefit of extended radical lymphadenectomy for patients with gastric cancer.
Ikeguchi M; Oka S; Gomyo Y; Tsujitani S; Maeta M; Kaibara N
Anticancer Res; 2000; 20(2B):1285-9. PubMed ID: 10810436
[TBL] [Abstract][Full Text] [Related]
58. Immunohistochemical expression of cell-cycle proteins in gastric precancerous lesions.
Anagnostopoulos GK; Stefanou D; Arkoumani E; Karagiannis J; Paraskeva K; Chalkley L; Habilomati E; Tsianos E; Agnantis NJ
J Gastroenterol Hepatol; 2008 Apr; 23(4):626-31. PubMed ID: 18397488
[TBL] [Abstract][Full Text] [Related]
59. Complex analysis of cyclin D1 expression in mantle cell lymphoma: two cyclin D1-negative cases detected.
Stefancikova L; Moulis M; Fabian P; Falkova I; Vasova I; Kren L; Macak J; Smardova J
J Clin Pathol; 2009 Oct; 62(10):948-50. PubMed ID: 19783727
[TBL] [Abstract][Full Text] [Related]
60. Cyclin D1 expression in astrocytomas is associated with cell proliferation activity and patient prognosis.
Sallinen SL; Sallinen PK; Kononen JT; Syrjäkoski KM; Nupponen NN; Rantala IS; Helén PT; Helin HJ; Haapasalo HK
J Pathol; 1999 Jul; 188(3):289-93. PubMed ID: 10419598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
